Grčka - grčki - Εθνικός Οργανισμός Φαρμάκων

astrazeneca a.e. - formoterol and other drugs for obstructive airway diseases - ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ - (160+4,5)mc/dose - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Grčka - grčki - Εθνικός Οργανισμός Φαρμάκων

astrazeneca a.e. - formoterol and other drugs for obstructive airway diseases - ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ - (320+9)mc/dose - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Grčka - grčki - Εθνικός Οργανισμός Φαρμάκων

orion corporation espoo, ΦΙΝΛΑΝΔΙΑ (0000003573) p.o.box 65, 02101 espoo, orionintie 1, 02200 espoo - budesonide; formoterol fumarate dihydrate - ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ - (80+4,5)μg/εισπνοή - 0051333223 budesonide 80.000000 mcg; 0183814304 formoterol fumarate dihydrate 4.500000 mcg - formoterol and budesonide

Grčka - grčki - Εθνικός Οργανισμός Φαρμάκων

orion corporation espoo, ΦΙΝΛΑΝΔΙΑ (0000003573) p.o.box 65, 02101 espoo, orionintie 1, 02200 espoo - budesonide; formoterol fumarate dihydrate - ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ - (160+4.5)mc/inhalation - 0051333223 budesonide 160.000000 mcg; ineof01061 formoterol fumarate dihydrate 4.500000 mcg - formoterol and budesonide

Grčka - grčki - Εθνικός Οργανισμός Φαρμάκων

astrazeneca a.e. - ΒΟΥΔΕΣΟΝΊΔΗ, formoterol fumarate dihydrate - ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΕΙΣΠΝΟΗ ΥΠΟ ΠΙΕΣΗ - (160+4.5)mcg/ΨΕΚΑΣΜΟ - 0051333223 - budesonide - 160.000000 mcg; 0183814304 - formoterol fumarate dihydrate - 4.500000 mcg - formoterol and budesonide

Europska Unija - grčki - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Europska Unija - grčki - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Grčka - grčki - Εθνικός Οργανισμός Φαρμάκων

win medica ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. win medica a.e. Οιδίποδος 1-3 & Παράδρομος Αττικής Οδού 33-35, 152 38 Χαλάνδρι 210.7488821 - budesonide; formoterol fumarate dihydrate - inh.pd.dos (ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ, ΣΕ ΔΟΣΕΙΣ) - (400+12)mcg/dose - budesonide 0,4mg; formoterol fumarate dihydrate 0,012mg - formoterol and budesonide

Grčka - grčki - Εθνικός Οργανισμός Φαρμάκων

win medica ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. win medica a.e. Οιδίποδος 1-3 & Παράδρομος Αττικής Οδού 33-35, 152 38 Χαλάνδρι 210.7488821 - budesonide; formoterol fumarate dihydrate - inh.pd.dos (ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ, ΣΕ ΔΟΣΕΙΣ) - (100+6)mcg/dose - budesonide 0,1mg; formoterol fumarate dihydrate 0,006mg - formoterol and budesonide

Grčka - grčki - Εθνικός Οργανισμός Φαρμάκων

win medica ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. win medica a.e. Οιδίποδος 1-3 & Παράδρομος Αττικής Οδού 33-35, 152 38 Χαλάνδρι 210.7488821 - budesonide; formoterol fumarate dihydrate - inh.pd.dos (ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ, ΣΕ ΔΟΣΕΙΣ) - (200+6)mcg/dose - budesonide 0,2mg; formoterol fumarate dihydrate 0,006mg - formoterol and budesonide